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A B S T R A C T
Background
Tracheomalacia, a disorder of the large airways where the trachea is deformed or malformed during respiration is commonly seen in
tertiary paediatric practice. It is associated with a wide spectrum of respiratory symptoms from life threatening recurrent apnea to
common respiratory symptoms such as chronic cough and wheeze. Current practice following diagnosis of tracheomalacia include
medical approaches aimed at reducing associated symptoms of tracheomalacia, ventilation modalities of continuous positive airway
pressure (CPAP) and bi-level positive airway pressure (BiPAP) and, surgical approaches aimed at improving the caliber of the airway
(airway stenting, aortopexy, tracheopexy).
Objectives
To evaluate the efficacy of medical and surgical therapies for children with intrinsic (primary) tracheomalacia.
Search methods
The Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Airways Group Specialised Register, MEDLINE and
EMBASE databases were searched by the Cochrane Airways Group. The latest searches were performed in February 2008.
Selection criteria
All randomised controlled trials of therapies related to symptoms associated with primary or intrinsic tracheomalacia.
Data collection and analysis
Results of searches were reviewed against pre-determined criteria for inclusion. No eligible trials were identified and thus no data were
available for analysis.
Main results
No randomised controlled trials (RCTs) that examined therapies for intrinsic tracheomalacia were found. Eight of the more recent (last
11 years) non randomised controlled trials reported a benefit from the various surgical interventions. The success was however not
universal and in some studies severe adverse events occurred.
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Authors’ conclusions
There is currently an absence of evidence to support any of the therapies currently utilised for management of intrinsic tracheomalacia.
It is unlikely that any RCT on surgically based management will ever be available for children with severe life threatening illness
associated with tracheomalacia. For those with less severe disease, RCTs are clearly needed. Outcomes of these RCTs should include
measurements of the trachea and physiological outcomes in addition to clinical outcomes.
P L A I N L A N G U A G E S U M M A R Y
Interventions for primary (intrinsic) tracheomalacia in children
The clinical spectrum of tracheomalacia in children ranges from minimal symptoms to severe life threatening disease. Available
medical and surgical approaches to treat symptoms associated with tracheomalacia range from simple medical therapies, ventilation ,
tracheostomy and stents to direct surgical approaches such as aorta/tracheopexy. Using the standard search module of the Cochrane
Airways Group, no randomised controlled trials that assessed any therapy for intrinsic tracheomalacia were found. With the lack of
evidence, the routine use of any therapies for intrinsic tracheomalacia cannot be assessed. The decision to subject a child to any surgical
or medical based therapies will have to be made on an individual basis, with careful consideration of the risk-benefit ratio for each
individual situation.
B A C K G R O U N D
Tracheomalacia is a disorder of the large airways where the tra-
chea is deformed ormalformed during respiration (Masters 2002).
Tracheomalacia is commonly seen in tertiary paediatric practice
(Masters 2002) and many of the children are only referred for as-
sessment after repeated failures of therapy which include asthma
drug therapies (Gormley 1999, Thomson 2002). This large air-
way disorder can be classified as primary (intrinsic abnormality
of the airway) or secondary (related to compression of trachea by
another structure such as a mass). Primary tracheomalacia may
occur in isolation, or in association with other malacia disorders
(laryngomalacia and bronchomalacia), as part of a syndrome (e.g.
Downs syndrome, Ehlers-Danlos syndrome), or with other con-
genital non-syndromic disorders (e.g. cardiac abnormalities, tra-
cheoesophageal fistula etc) (Austin 2003, Masters 2002). Some
have classified tracheomalacia associated with other abnormalities
as secondary tracheomalacia assuming that it is related to the com-
pression effects. However, as embryologically these tracheomala-
cia are related to a developmental abnormality with the associ-
ated condition (as opposed to because of the associated condition)
(Beasley 1998) and in general do not totally resolve after correc-
tion of the associated problem (such as in tracheo-oesophageal
fistula (Kovesi 2004) or after thoracic vascular surgery (Horvath
1992, van 1993), we have classified these types of tracheomala-
cia as primary tracheomalacia with associated abnormalities. True
secondary tracheomalacia generally resolves on removal of the of-
fending agent (such as a mediastinal mass or lymph node) and
thus will not be discussed in this review.
Tracheomalacia may be diagnosed by flexible and rigid bron-
choscopy, radiological airway screening, chest computed tomog-
raphy (CT) scan, magnetic resonance imaging or tracheo-bron-
chogram. The current gold standard of diagnosing tracheomala-
cia is by visual assessment during bronchoscopy (Wright 2003)
and flexible bronchoscopy is superior to rigid bronchoscopy for
evaluation of tracheo-bronchomalacia (Midulla 2003). Flexible
bronchoscopy provides the best assessment for the dynamic airway
changes found in tracheo-bronchomalacia (Midulla 2003). The
other methods of diagnosis are less reliable and/or have major pit-
falls. During flexible bronchoscopy, different visual descriptions of
tracheomalacia have been described (Masters 2002). However the
associated symptoms are similar (Masters 2002). The most com-
mon symptoms at presentation are persistent respiratory symp-
toms in particular chronic cough and wheeze. These symptoms
cover most of the common respiratory symptoms seen in children
and thus it not surprising that diagnosis is often delayed (Masters
2002, Wood 1997, Gormley 1999). Gormley and colleagues de-
scribed that 75% of children with congenital tracheomalacia sec-
ondary to congenital vascular anomaly had persistent cough at pre-
sentation (Gormley 1999). As these symptoms overlap with other
respiratory disorders, it is also not surprising that the diagnosis
andmanagement of tracheomalacia is often sub-optimal (Gormley
1999). Other respiratory symptoms include recurrent infections
and pneumonia, recurrent cyanosis, stridor, exertional dyspnoea
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and effort intolerance. Severe tracheomalacia may also be associ-
ated with difficult anaesthesia (Austin 2003) and increased CO2
value during flexible bronchoscopy under general anaesthesia is
associated with these airway lesions (Chang 2004). Non respira-
tory symptoms related to tracheomalacia have also been described
and these include dysphagia (Agrawal 1999) and gastroesophageal
reflux (Bibi 2001).
The respiratory symptoms attributed to tracheomalacia are most
likely primarily to be related to the effect of a narrowed airway
generating altered airflow. Wheeze is generated from altered flow
through a narrowed tube. Misdiagnosis of asthma in children with
airway malacia disorders has been well described (Finder 1997).
Cough is likely related to reductionofmuco-ciliary clearance as the
compressed airway impedes clearance of secretions (Finder 1997)
which sets up a bronchitic process distal to the lesion. Exactly
why this occurs is unknown but the possibility of a more subtle
process that involves functional abnormalities in the development
of the neuro-vascular and airway immunological, smooth muscle
and epithelial cell lines would be biologically possible, but have
not been described. Thus, it is also plausible that a change in
anatomical improvement (if possible) may not necessary result in
symptomatic improvement.
Current practice following diagnosis of tracheomalacia include
medical approaches aimed at reducing associated symptoms of tra-
cheomalacia and surgical approaches aimed at improving the cal-
iber of the airway (airway stenting, aortopexy) and thus reducing
associated symptoms. These interventions may have serious and
significant adverse events. Hence, there is a need for systematic
evaluation of the effects of interventions aimed at reducing the
respiratory symptoms related to tracheomalacia.
O B J E C T I V E S
To evaluate the efficacy of medical and surgical therapies for chil-
dren with intrinsic (primary) tracheomalacia.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials of therapies related to symptoms
associated with primary or intrinsic tracheomalacia.
Types of participants
Children aged < 15 years with tracheomalacia with associated res-
piratory symptoms.
Exclusion criteria: secondary tracheomalacia.
Types of interventions
All randomised controlled comparisons of therapies for symptoms
associated with primary or intrinsic tracheomalacia. Trials that in-
cluded the use of othermedications or interventionswere included
if all participants had equal access to such medications or inter-
ventions.
Types of outcome measures
It was planned to obtain data on at least one of the following
outcome measures:
Primary outcome:
a) proportions of participants who were not cured or not substan-
tially improved at follow up (clinical failure)
Secondary outcomes:
b) proportions of participants who were not cured at follow up
c) proportions of participants who not substantially improved at
follow up
d) mean difference in number of respiratory episodes (defined by
diary cards or acute respiratory illness score)
e) proportions requiring hospitalisation for respiratory illness
f ) mean difference in symptoms and signs (mean improvement in
clinical state)
g) proportions developing new respiratory complications such as
bronchiectasis, bronchiolitis obliterans, etc.
h) proportions requiring acute or complicated airway intervention
(prolonged intubation, tracheostomy, etc.)
i) proportions experiencing adverse effects of the intervention (e.g.
death from surgery, surgical complications etc.)
The proportions of participants who failed to improve on treat-
ment and the mean clinical improvement were to be determined
using the following hierarchy of assessment measures (i.e. where
two or more assessment measures are reported in the same study,
the outcome measure that is listed first in the hierarchy would be
used).
i) Objective measurements of cough indices (cough frequency)
ii) Symptomatic (Quality of life, Likert scale, visual analogue
scale, level of interference of respiratory symptoms such as cough,
wheeze, cyanotic events etc using diaries) - assessed by child
iii) Symptomatic (Quality of life, Likert scale, visual analogue
scale, level of interference of respiratory symptoms such as cough,
wheeze, cyanotic events etc using diaries) - assessed by the parents/
carers
iv) Symptomatic (Likert scale, visual analogue scale, level of inter-
ference of respiratory symptoms such as cough, wheeze, cyanotic
events etc using diaries) - assessed by clinicians
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v) Pulmonary function tests
vi) Bronchoscopic assessment of tracheomalacia (using flexible
bronchoscopy)
vii) Relevant airway markers consistent with neutrophilic inflam-
mation
Search methods for identification of studies
The following topic search strategy was used to identify the
relevant randomised controlled trials listed on the electronic
databases:
(“ tracheomalacia ” OR “ tracheo-malacia ” OR “malacia” OR “
trachea abnormalities” OR “tracheal diseases” all as (text word) or
(MeSH)) AND (“child” OR “children”OR “infant” as (text word)
or (MeSH))
The full search strategies are shown in Table 1 and Table 2.
Trials were identified from the following sources:
1. The Cochrane Controlled Trials Register (CENTRAL) which
includes the Airways Collaborative Review Group Specialised Tri-
als Register
2. MEDLINE 1966-2004. Topic search strategy combined with
the MEDLINE randomised controlled trial search filter as out-
lined in the Airways Group module
3. OLDMEDLINE 1951-1965. Topic search strategy combined
with the MEDLINE randomised controlled trial search filter as
outlined in the Airways Group module
4. EMBASE 1980-2004. Topic search strategy combined with the
EMBASE randomised controlled trial search filter as outlined in
the Airways Group module
5. The list of references in relevant publications
6. Written communication with the authors of trials included in
the review when necessary
The latest searches were performed in February 2008
Data collection and analysis
Study Selection
Retrieval of studies: From the title, abstract or descriptions, two
reviewers independently reviewed literature searches to identify
potentially relevant trials for full review. Searches of bibliographies
and texts were conducted to identify additional studies. From the
full text using specific criteria, the same two reviewers indepen-
dently selected trials for inclusion. Agreement would have been
measured using Kappa statistics. Disagreement would have been
resolved by consensus.
Assessment of Quality
Studies included in the review would have undergone quality as-
sessment performed independently by both reviewers. Four com-
ponents of quality would have been assessed:
1. Allocation concealment. Trialswould have been scored as:Grade
A: Adequate concealment, Grade B: Unclear, Grade C: Clearly
inadequate concealment (Grade A = high quality)
2. Blinding. Trials would have been scored as: Grade A: Participant
and care provider and outcome assessor blinded, Grade B: Out-
come assessor blinded, Grade C: Unclear, Grade D: No blinding
of outcome assessor (Grade A, B = high quality)
3. Reporting of participants by allocation group. Trials would have
been scored as: Grade A: The progress of all randomised children
in each group described, Grade B: Unclear or no mention of with-
drawals or dropouts, GradeC: The progress of all randomised chil-
dren in each group clearly not described (Grade A = high quality)
4. Follow-up. Trials would have been scored as: Grade A: Out-
comes measured in >90% (where withdrawals due to complica-
tions and side-effects are categorised as treatment failures), Grade
B: Outcomes measured in 80 to 90%, Grade C: Unclear, Grade
D: Outcomes measured in <80% (Grade A = high quality)
While only the allocation concealment quality would have been
displayed in the meta-analysis figures, all assessments would have
been included in the ’Characteristics of included studies’ table. In-
ter-reviewer reliability for the identification of high quality stud-
ies for each component would have been measured by the Kappa
statistic.
Each study would have been assessed using a one to five scale
described by Jadad (Jadad 1996) and summarised as follows:
Was the study described as randomised? (1= yes; 0 = no)
Was the study described as double blind? (1= yes; 0 = no)
Was there a description of withdrawals and dropouts? (1= yes; 0 =
no)
Was the method of randomisation clearly described and appropri-
ate? (1= yes; 0 = no)
Was the method of double blinding well described and appropri-
ate? (1= yes; 0 = no)
Data Extraction
Trials that satisfy the inclusion criteria would have been reviewed
and the following information recorded: study setting, year of
study, source of funding, patient recruitment details (including
number of eligible children), inclusion and exclusion criteria, ran-
domisation and allocation concealment method, numbers of par-
ticipants randomised, blinding (masking) of participants, care
providers and outcome assessors, intervention (duration and type),
control, co-morbidities (all medical problems with particular at-
tention to genetic syndromes and co-morbidities), existing respi-
ratory problems, co-interventions, numbers of patients not fol-
lowed up, reasons for withdrawals from study protocol (clinical,
side-effects, refusal and other), details on side-effects of therapy,
and whether intention-to-treat analyses were possible. Data would
have been extracted on the outcomes described previously. Further
information would have been requested from the authors where
required.
Data Analysis
For the dichotomous outcome variables of each individual study,
relative and absolute risk reductions would have been calculated
using a modified intention-to-treat analysis. This analysis assumes
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that children not available for outcome assessment have not im-
proved (and probably represents a conservative estimate of effect).
An initial qualitative comparison of all the individually analysed
studies would examine whether pooling of results (meta-analysis)
is reasonable. This would take into account differences in study
populations, inclusion/exclusion criteria, interventions, outcome
assessment and estimated effect size.
The results from studies that meet the inclusion criteria and re-
ported any of the outcomes of interest would have been included
in the subsequent meta-analysis. The summary weighted risk ratio
and 95% confidence interval (fixed-effectmodel) would have been
calculated using the inverse of the variance of each study result
for weighting (Cochrane statistical package, RevMan 4.2). Num-
bers needed to treat (NNT) would have been calculated from the
pooled OR and its 95% CI applied to a specified baseline risk us-
ing an online calculator (Cates 2003). This calculator converts the
risk in the placebo group to the corresponding odds, applies the
OR to estimate the odds in the treated group, and converts that
odds to the corresponding risk and calculates the risk difference,
the inverse of which is the NNT. The outcome indices would have
been assumed to be normally distributed continuous variables so
themean difference in outcomes can be estimated (weightedmean
difference). If studies reported outcomes using different measure-
ment scales, the standardised mean difference would have been es-
timated. In cross-over trials, if data is combined with parallel stud-
ies only data from the first arm would have been used (Elbourne
2002). In addition, for pooled cross-over studies, mean treatment
differences would have been calculated from raw data, extracted or
imputed and entered as fixed effects generic inverse variance (GIV)
outcome to give weighted SD unit difference and 95% confidence
intervals (RevMan 4.2). Heterogeneity between the study results
would have been tested to see if it reached statistical significance
using a chi squared test, and the proportion of heterogeneity aris-
ing from between study differences would have been assessed with
the I2 statistic (Higgins 2003). The 95% confidence interval es-
timated using a random-effects model would have been included
whenever there are concerns about statistical heterogeneity.
SUB-GROUP ANALYSIS:
An a priori subgroup analysis was planned for
1. Age: infants (<12 months) or children (aged 1-14 years)
2. Presence of congenital (cardiac, tracheoesophageal fistula) or
syndromes
3. Medical therapies
4. Surgical therapies
Sensitivity analyses was planned to assess the impact of the poten-
tially important factors on the overall outcomes:
a) study quality
b) study size
c) variation in the inclusion criteria
d) differences in other medications used in the intervention and
comparison groups
e) differences in outcome measures
f ) analysis using random-effects model
g) analysis by ’treatment received’
h) analysis by ’intention-to-treat’
i) analysis by study design: parallel and cross over studies
Publication bias would have been tested using a funnel plot.
R E S U L T S
Description of studies
See: Characteristics of excluded studies.
The searches identified 13 potential studies but none fulfilled the
study eligibility criteria. An update search run in February 2008
yielded 41 references of which none met the eligibility criteria of
the review.
Risk of bias in included studies
Not applicable.
Effects of interventions
The Airways Group search identified 757 potentially relevant ti-
tles. After assessing the abstracts, 13 studies were considered for in-
clusion into review but none fulfilled the study eligibility criteria.
Eight of the more recent non controlled studies are summarised
in the excluded table.
D I S C U S S I O N
No randomised controlled trials of therapies for symptoms asso-
ciated with primary or intrinsic tracheomalacia were identified.
There are numerous cohort descriptive studies with varying num-
bers of patients that reported on a variety of interventions (mainly
surgical) to increase the airway caliber. Most of these children
managed surgically had presumably the severe end of the clini-
cal spectrum, with life threatening apnoea episodes. These cohort
studies (see excluded table) have highlighted the importance of in-
terventions in terms of clinical improvement. However these sur-
gical procedures (tracheopexy, aortopexy and/or stenting) are not
universally successful and have associated morbidity and mortality
(Valerie 2005). CPAP alters forced expiratory flow in infants but
the authors did not describe clinical correlates (Davis 1998). There
are no studies that quantitatively defined severity either anatom-
ically or clinically. Also, when tracheomalacia is associated with
a vascular compression, surgical correction of the vascular com-
pression alleviates major respiratory symptoms in most (68%) but
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not in a significant number of children (Bonnard 2003, Benjamin
1976).
Physiological measurement studies of lung function have shown
short-term benefits in function in lung mechanics and improve-
ment in spirometric parameters for selective children managed
with surgical intervention (Zinman 1995) and CPAP (Davis
1998). However there are no quantitative assessments of severity
of the tracheomalacia at the entry or end point. Interpretation of
lung function may be limited unless paired (pre and post interven-
tion) data are obtained, as children with these airway abnormali-
ties may have reduced lung growth (Agrawal 1999). At the mild
end of the spectrum there are no studies that have assessed the
disease impact, the management of intercurrent respiratory illness
or symptoms associated with tracheomalacia.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
With the lack of evidence, recommendations for the routine use
of any therapies for intrinsic tracheomalacia cannot be made. The
decision to subject a child to surgical and/or medical based thera-
pies will have to be made on an individual basis, with careful con-
sideration of the risk-benefit ratio for each individual situation.
Implications for research
It is unlikely that any RCT on surgically based management will
ever be available for children with severe life threatening illness
associated with tracheomalacia. For those with less severe disease,
RCTs are clearly needed. In these RCTs, outcomes should include
measurements of the trachea and physiological based outcomes in
addition to clinical outcomes.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abdel-Rahman 2002 Non controlled study. Authors reported on effect of aortopexy on 16 infants and children with tracheomala-
cia. No intraoperative or postoperative mortality occurred and 13 (81%) had permanent relief of symptoms
Corbally 1993 Non controlled study. Authors reported on 48 patients with repaired congenital oesophageal anomaly who
underwent aortopexy for significant tracheomalacia. Indications for aortopexy included recurrent apnoea/
cyanosis, near fatal episodes, recurrent respiratory distress and infection and worsening stridor. Aortopexy
cured near fatal episodes in all patients and resulted in improvement of airway obstruction in 95%. The
procedure failed in 2 patients due to unrecognised bronchomalacia and phrenic nerve palsy
Davis 1998 Non controlled study. Continuous positive airway pressure (CPAP) was used to minimize airway collapse
in infants with tracheomalacia. Forced expiratory flows increased with CPAP use
Filler 1993 Non controlled study. The authors reported on their 5-year experience of inserting the Palmaz stent into
infants and children who had a variety of major airway obstructions, including tracheomalacia in 8 children.
Granulation tissue developed over the stents in five of eight cases. Obstructing granulations were removed
by scraping or balloon compression in three and resulted in earlier than the planned removal in two
McCarthy 1997 Non controlled study. Twenty-four infants and children with various causes of airway obstruction including
tracheomalacia. Hospital mortality was 8.7%, 19 (79.2%) patients were alive and symptom free. The single
most important predictor of mortality was the presence of associated cardiac anomalies
Nicolai 2001 Non controlled study. Authors reported on 7 children with extreme structural central airway obstruction (6
were mechanically ventilated). All patients showed marked improvement of their respiratory obstruction;
6 were weaned at least temporarily from ventilation. Three children are well and at home
Vazquez-Jimenez 2001 Non controlled study. Authors reported on 29 children operated for tracheomalacia associated with oe-
sophageal atresia. No early nor late mortality occured. Surgery associated morbidity were: reversible lesion
of the phrenic nerve was observed in 2 patients, a pneumothorax in 3, and secondary wound healing in 1.
In all but one patient symptoms improvedmarkedly or disappeared within days or within the first 3 months
postoperatively. An increased susceptibility to respiratory infections was observed in long-term follow-up
of children
Vinograd 1994 Non controlled study. Authors reported on surgical management (aortopexy) of 54 children with airway
problems, of whom 20 had tracheomalacia. No operative deaths occured
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. MEDLINE search strategy
1. tracheomalac$.mp.
2. tracheo-malac$.mp.
3. (trache$ adj5 malac$).mp.
4. malacia$.mp.
5. exp Tracheal Diseases/dt, su, th [Drug Therapy, Surgery, Therapy]
6. exp TRACHEA/ab, su [Abnormalities, Surgery]
7. exp BRONCHI/ab [Abnormalities]
8. (trache$ adj5 abnormal$).mp.
9. or/1-8
10. ADOLESCENT/ or exp CHILD/ or exp INFANT/ or exp PEDIATRICS/
11. (child$ or paediat$ or pediat$ or adolesc$ or infan$ or toddler$ or bab$ or young$ or preschool$ or pre school$ or pre-school$
or newborn$ or new born$ or new-born$ or neo-nat$ or neonat$).mp
12. 10 or 11
13. 9 and 12
Table 2. EMBASE search strategy
1. tracheomalac$.mp.
2. tracheo-malac$.mp.
3. (trache$ adj5 malac$).mp.
4. malacia$.mp.
5. (trache$ adj5 abnormal$).mp.
6. exp TRACHEOMALACIA/
7. or/1-6
8. exp pediatrics/
9. exp CHILD/ or exp INFANT/ or exp ADOLESCENT/
10. (child$ or paediat$ or pediat$ or adolesc$ or infan$ or toddler$ or bab$ or young$ or preschool$ or pre school$ or pre-school$
or newborn$ or new born$ or new-born$ or neo-nat$ or neonat$).mp.
11. 8 or 9 or 10
12. 7 and 11
WH A T ’ S N E W
Last assessed as up-to-date: 31 January 2008.
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Date Event Description
7 April 2008 Amended Search re-run; no new studies identified for inclusion in the review
H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 4, 2005
Date Event Description
7 April 2008 Amended Converted to new review format.
25 July 2005 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
IBM: formulation and writing of protocol. AC: initiation, formulation and writing of protocol. For the review- both IBM and AC:
review and selection of studies from search, data extraction and writing of review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Royal Children’s Hospital Foundation, Brisbane, Australia.
External sources
• National Health and Medical Research Council, Australia.
10Interventions for primary (intrinsic) tracheomalacia in children (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Adolescent; Trachea [∗abnormalities]; Tracheal Diseases [∗therapy]
MeSH check words
Child; Humans
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